amplifyeyecare-logo-base2-icon
Authors
Han, Sang Beom; Yang, Hee Kyung; Kim, Jonghyun; Hong, Keehoon; Lee, Byoungho; Hwang, Jeong-Min

Quantification of Stereopsis in Patients with Impaired Binocularity

publication date
Category
see more

Abstract/Introduction

Purpose 

To quantify stereopsis at distance resulting from binocular fusion in patients with impaired binocular vision using a three-dimensional (3-D) display stereotest.

 

Methods 

A total of 68 patients (age range, 6 to 85 years) with strabismus (40 esotropes and 28 exotropes) whose stereoacuity could not be measured with the near and distance Randot stereotests were included. Contour-based circles with a wide range of crossed horizontal disparities (2500 to 20 arcsec) displayed on a 3-D monitor were presented to subjects at 3 m. Between the patients who had stereoacuity of at least 2500 arcsec and those with no measurable stereoacuity, parameters including age, sex, best-corrected visual acuity, spherical equivalent refractive error, Worth 4 dot test results, and type and angle of deviation were compared.


Conclusion/Results

Results 

Stereoacuity at distance of 2500 arcsec or better was detected in 25 (63%) of 40 esotropes, and 16 (57%) of 28 exotropes, although stereoacuity of 800 arcsec or better was found only in two (5%) esotropes and one (4%) exotrope. Patients with stereopsis were significantly younger (19.3 ± 16.9 years) than those with no measurable stereopsis (31.5 ± 26.4 years) (p = 0.040). There were no significant differences in best-corrected visual acuity, presence of amblyopia >20/100, spherical equivalent refractive error, type of deviation, deviation angle, sex, and Worth 4 dot test results between these groups.

 

Conclusions 

Stereopsis at distance resulting from binocular fusion that cannot be measured with conventional stereoacuity tests may be preserved in patients with impaired binocular vision. The 3-D display stereotest can be useful for quantifying stereopsis at distance resulting from binocular fusion.


Contact Us To Amplify Your EyeCare

Learn More 

arrow-uparrow-right